The global API intermediate market is anticipated to grow at a significant CAGR of 7.5% during the forecast period 2022-2028. API intermediates are chemicals or agents that are employed in the manufacture of active pharmaceutical ingredients and are used as raw materials (API). Amination, hydrogenation, alkoxylation, hydroformylation, electrochemistry, acetylene chemistry, and phosgene chemistry are few of the methods employed to make these intermediates. The expanding usage of generic pharmaceuticals, increase in abbreviated new drug applications, together with the growing geriatric population, are the primary drivesr of market growth.
To Request a Sample of our Report on Global API Intermediate Market: https://www.omrglobal.com/request-sample/api-intermediate-market
For instance, in 2019, the US Food and Drug Administration (FDA) granted provisional approval to more than 1,000 generic medications, according to the FDA. As a result, demand for API intermediates for generic medication manufacture is increasing. Furthermore, the Department of Economic and Social Affairs estimates that there were 703 million individuals aged 65 and up in the world in 2019, with that number expected to quadruple to 1.5 billion by 2050. Because the geriatric population is more prone to neurological illnesses and chronic diseases, the demand for API intermediates in the manufacture of medications to treat these problems is increasing. During the projection period, however, the worldwide API intermediate market would be hampered by strict government restrictions.
Some major players in the market include BASF SE, Sanofi S.A., and Pfizer Inc., among others. To stay competitive in the market, market players are using a variety of strategies such as mergers and acquisitions, regional expansion, partnerships and collaborations, and new product releases to contribute significantly to market growth. For instance, in February 2020, Sanofi SA announced the formation of a separate company by consolidating Sanofi’s API sales and development activities at six of its European manufacturing sites. The spin-off firm, EUROAPI, will be launched in 2022, according to the corporation.
A full Report of Global API Intermediate Market is Available @ https://www.omrglobal.com/industry-reports/api-intermediate-market
Global API Intermediate Market Segmentation
By Product
- Chemical Intermediates
- Biotech Intermediates
By Type of Intermediate
- Patent Intermediates
- Non-Patent Intermediates
By Therapeutic Application
- Oncology
- Diabetes
- Cardiovascular Disease
- CNS & Neurological Disorders
- Endocrinology
- Others
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Hipharma Ltd.
- Jigs Chemical Ltd
- Pfizer Inc.
- Sanofi Winthrop Industrie SA
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Dragon Hwa ChemPharm. Co., Ltd.
- Shandong Jiulong Fine Chemical Co., Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/api-intermediate-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
